Generate a tailored SOP for Dr. Daniel Nomura. Improve your application with a focused, well-structured draft.
Dan Nomura is a Professor at the University of California, Berkeley, holding joint appointments in the Department of Chemistry and the Department of Molecular and Cell Biology. He is also the Co-Director of the Molecular Therapeutics Initiative and an investigator at the Innovative Genomics Institute. Dr. Nomura's research focuses on developing chemoproteomic platforms to tackle the 'undruggable' proteome, aiming to discover transformative medicines for cancer and other diseases. His contributions include co-founding several biotech companies that leverage chemoproteomic technologies, and he has served on various scientific advisory boards. He has received numerous honors, including the National Cancer Institute Outstanding Investigator Award and being named a Searle Scholar. His lab is committed to advancing chemical technologies in drug discovery, with ongoing projects aimed at discovering new therapeutic modalities and expanding targeted protein degradation techniques.
The Mathematics Subject GRE is required for the Fall 2026 admissions cycle. General GRE is optional.